Where is Tilda Bio located?

Tilda Bio is headquartered in San Francisco, United States.

Who is the current CEO of Tilda Bio?

Ram Yalamanchili of Tilda Bio. They have also founded 1 company.

How many employees does Tilda Bio have?

As of Oct 31, 2026, the latest employee count at Tilda Bio is 64.

Where does Tilda Bio rank among its competitors?

Tilda Bio ranks 14th amongst 209 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioMADE, which secured $2.42M in Aug, 2025.

Tilda Bio - 2026 Company Profile, Team, Funding & Competitors

Q: Who are the top competitors of Tilda Bio?

Tilda Bio's top competitors include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Among them, BioMADE secured the most recent funding round in August, 2025.

Company Details

Provider of clinical trial execution services to sponsors and CROs. The company leverages Patient Recruitment and Enrollment, Regulatory Documentation, data integration, site-wide automation, and real-time monitoring to streamline clinical trials. It also specializes in executing studies across various medical fields, including Alzheimer’s and infectious diseases.

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Funding Raised

Investors

8VC

Ranked

14^th among 209 active competitors

Employee Count

64 as on Oct 31, 2026

Similar Companies

Javara Research & 253 more

View Tilda Bio's full profile

Tilda Bio is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
TILDA RESEARCH INC. CIN: 07485730 , United States, Active	Jun 25, 2019	-	-	-
TILDA RESEARCH INC. CIN: 7485730 , United States, Active	Jun 25, 2019	-	2 (As on Jan 31, 2020)	-

Tilda Bio is a funded company. Tilda Bio has 1 institutional investor.

View details of Tilda Bio's funding rounds and investors

The founders of Tilda Bio is Ram Yalamanchili. Ram Yalamanchili is the CEO of Tilda Bio.

Here are the details of Tilda Bio's key team members:

Ram Yalamanchili: Founder & CEO of Tilda Bio.
Contact Info: 1 email address

View details of Tilda Bio's Founder profiles and Board Members

Tilda Bio's employee count trend

Tilda Bio has 64 employees as of Oct 26. Here is Tilda Bio's employee count trend over the years:

Uncover Tilda Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tilda Bio include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Here is the list of Top 10 competitors of Tilda Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Javara Research 2018, Winston-salem (United States), Series B	Integrating clinical research at the point of care for better outcomes	$45M	General Atlantic, Dioko Ventures & 1 others	44/100
2nd	Alcanza Clinical Research 2021, Methuen (United States), Funding Raised	Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation	-	Impact Engine, Martis Capital	43/100
3rd	The START Center for Cancer Research 2007, San Antonio (United States), Series B	Provider of early-phase oncology clinical trials and research services	$16.9M	Warburg Pincus	42/100
4th	Vial 2020, San Francisco (United States), Series B	-	$100M	General Catalyst, BoxGroup & 1 others	42/100
5th	BioMADE 2020, Saint Paul (United States), Funding Raised	Provider of clinical trial research site services for biopharma sector	-	National Oceanic and Atmospheric Administration, National Science Foundation ... Read more	42/100
6th	Tekton Research 2006, Austin (United States), Acquired	Clinical research site network conducting Phase 1-4 trials across multiple therapeutic areas	-	-	41/100
7th	Care Access 1998, Boston (United States), Unfunded	CRO offering clinical sites which conduct clinical trials	-	-	39/100
8th	Summit Clinical Research 2018, San Antonio (United States), Acquired	CRO providing research site for clinical development services	-	LongueVue Capital	38/100
9th	Meridien Research 2000, Tampa (United States), Acquired	Clinical trial services for research and development	-	Balance Point Capital, Fletch Equity	36/100
10th	Sampled 1999, Motherwell (United Kingdom), Funding Raised	Provider of smart laboratory services for drug developers	-	Pioneer Group	35/100
14th	Tilda Bio 2017, San Francisco (United States), Funding Raised	Provider of clinical trial execution services to sponsors and CROs	-	8VC	39/100